Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2316 of 6351
-
New brain aneurysm device under study – could reduce clot risk
Disease control Recruiting nowThe Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked i…
Sponsor: Jacobs institute • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can heart MRI be safe for patients with old or broken wires? a new study investigates
Knowledge-focused By invitation onlyThis is a prospective cohort study looking to systematically evaluate the safety of conducting cardiac Magnetic Resonance Imaging (MRI) in this high-risk patient group with abandoned, fractured endocardial leads or surgically implanted permanent epicardial leads, by monitoring cl…
Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Bone scintigraphy may outshine CT scans in spotting hidden neck fusion failures
Diagnosis Recruiting nowCervical pseudarthrosis is a classic complication and a challenge for challenge for spine surgeons. The rate of pseudarthrosis can range from 3 to 15%, and depend greatly on the patient, the approach the number of levels operated on. Although some patients remain asymptomatic, m…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Diagnosis
Last updated Jul 18, 2026 00:00 UTC
-
Heart rehab at home: App-Based program aims to shrink artery plaque
Disease control Recruiting nowThis single-center, randomized controlled trial aims to evaluate the efficacy of a mobile internet-based, home-based cardiac rehabilitation program in patients with mild to moderate coronary artery stenosis. A total of 176 eligible participants will be randomized to receive eithe…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New eye drops aim to soothe dry eyes in major trial
Symptom relief CompletedThis study will evaluate the safety and efficacy of SJP-0132 in Chinese Patients with Dry Eye. Patients will be randomly assigned to receive either SJP-0132 or placebo.
Phase 3 • Sponsor: Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Quick cholesterol fixes may slash heart attack risk
Disease control Recruiting nowHyperlipidaemia especially elevation of low-density lipoprotein cholesterol (LDL-C) is known to be the main contributor to the development of atherosclerotic cardiovascular disease (ASCVD). Lowering LDL-C have been shown to reduce the risk of ASCVD2,3. Both the American Heart As…
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a pacemaker for the vagus nerve ease PTSD?
Symptom relief Recruiting nowObjectives of this study are to provide continued safety assessment for the ReStore system, and to gain further estimates of the effect size of Vagus Nerve Stimulation (VNS) therapy with Prolonged Exposure Therapy (PE) compared to PE with placebo (sham) stimulation in participant…
Sponsor: The University of Texas at Dallas • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New study reveals best technique for kidney stone removal
Symptom relief CompletedThis completed randomized clinical study was designed to compare three different techniques of retrograde intrarenal surgery (retrograde intrarenal surgery) for the treatment of kidney stones that are 2 centimeters or smaller. Retrograde intrarenal surgery is a minimally invasive…
Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New device could help heart failure patients avoid repeat hospital stays
Disease control Recruiting nowThe goal of this clinical trial is to test whether using Bioimpedance Analysis (BIA) can help manage fluid levels in patients with heart failure who are admitted to the hospital with worsening symptoms. The main questions it aims to answer are: 1\. Does BIA-guided fluid manageme…
Sponsor: Mid and South Essex NHS Foundation Trust • Aim: Disease control
Last updated Jun 26, 2026 16:58 UTC
-
Forecasting depression relapse: new study aims to predict the unpredictable
Knowledge-focused Recruiting nowMajor depressive disorder (MDD) is a common condition involving recurring periods of depression. One of the major challenges faced by people with MDD is that the episodes of depression tend to recur even after they are successfully treated. Currently, it is hard to predict when a…
Sponsor: Abraham Nunes • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
New pill aims to lift depression in days, not weeks
Symptom relief CompletedThe purpose of this study is to evaluate how well JNJ-89495120 works (anti-depressant effects) and how well it is tolerated as compared to placebo on reducing the symptoms of depression in participants with major depressive disorder (MDD).
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Diet change may boost sperm health in IVF couples
Knowledge-focused Recruiting nowIn this study, patients with infertility treated with IVF at the Center of Reproductive Medicine in Linköping, Sweden, will receive recipes and food according to Nordic dietary guidelines. The purpose is to investigate whether a short diet intervention is sufficient to improve sp…
Sponsor: Ostergotland County Council, Sweden • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Can a single gene therapy dose keep working for 14 years?
Knowledge-focused Recruiting nowThis LTFU is being conducted to assess long-term safety and durability of response in participants dosed with IP in a parent protocol, and to collect longitudinal natural history in enrolled but not dosed participants who also participated in a parent protocol.
Sponsor: iECURE, Inc. • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
New hope for high potassium: phase 3 drug trial launches
Disease control Recruiting nowThis clinical trial consists of 2 parts, Part A and Part B. Part A consists of a 2-day randomized, double-blind, placebo-controlled corrective phase (CP) and a 28-day randomized, double-blind, placebo-controlled maintenance phase (MP). Part B (open-label extension, OLE) is an ope…
Phase 3 • Sponsor: Waterstone Pharmaceutical (Wuhan) Co., LTD. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Exercise program may boost quality of life and cut costs for breast cancer patients
Symptom relief Recruiting nowAdapted physical activity (APA) was recognized as a non-drug therapy by the French Health Authority (HAS) in 2011. Very few studies have examined the efficiency of APA programs during the active phase of treatment in cancer patients. The investigators assumed that non-drug therap…
Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Bathroom breakthrough: new wash may stop UTIs in older women
Prevention OngoingA two-arm randomized control trial evaluating rates of urinary tract infection in post-menopausal women on vaginal estrogen with recurrent urinary tract infections.
Phase 4 • Sponsor: Oregon Health and Science University • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC
-
New recovery pathway aims to cut repeat surgeries for brain bleed in elderly
Disease control Recruiting nowA chronic subdural hematoma (cSDH) is a type of intracranial hematoma that primarily affects older adults. The rising incidence of this condition, coupled with the high healthcare burden of this disease, calls for an update of the medical care program. We introduced an enhanced r…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Real-World data may reveal best Second-Line therapy for multiple myeloma
Knowledge-focused CompletedThis retrospective observational study will use data from the OneOncology United States database to evaluate clinical outcomes in adults with relapsed/refractory multiple myeloma who received pomalidomide-containing or non-pomalidomide-containing treatment as second-line or third…
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New sedative may prevent Post-Surgery confusion in seniors
Symptom relief CompletedThere are many factors that make elderly patients prone to POD. On the basis of these factors, surgery and anesthesia can increase the incidence of POD in elderly patients. Deep depth of intraoperative anesthesia and persistent hypotension may increase the risk of POD occurrence …
Phase 4 • Sponsor: Wang Tianlong • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New hope for scleroderma: arthritis drug tofacitinib tested against skin thickening
Disease control CompletedThis study aims to evaluate the efficacy of Tofacitinib compared to Methotrexate (MTX) in reducing skin thickening in patients with diffuse cutaneous systemic sclerosis (dcSSc). Systemic sclerosis is a chronic autoimmune disease characterized by skin fibrosis and internal organ i…
Phase 4 • Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC